Published in:
Open Access 01-12-2019 | Sarcoma | Commentary
Detection of SS18-SSX1/2 fusion transcripts in circulating tumor cells of patients with synovial sarcoma
Published in: Diagnostic Pathology | Issue 1/2019
Login to get accessAbstract
A recent study on 15 patients with synovial sarcoma demonstrated very low prevalence of tumor-specific fusion transcripts in peripheral blood specimens. Our results in an independent cohort of 38 patients with synovial sarcoma support these findings. Synovial sarcoma patients could greatly benefit from a non-invasive monitoring of tumor burden by liquid biopsies. However, given the low detection rate of SS18-SSX1/2 in circulation, we conclude that alternative markers other than the tumor-type specific fusion transcripts should be considered.